ULBPs and MICA/B are NKG2D ligands involved in enhancing killing by cytotoxic lymphocytes such as αβ and γδ T-cells and NK cells, so, their upregulation on tumour cells is relevant to the immune response to tumour. The gene discussed is KLRK1; the disease is neoplasm.